1.
Folia Med (Plovdiv)
; 65(5): 728-736, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38351754
RESUMO
AIM: To compare the main features of patients with secondary acute myeloid leukemias (AMLs) after post-myelodysplastic syndrome (AML-post-MDS) or post-myeloproliferative neoplasms (AML-post-MPN) and myeloid blast crisis of chronic myeloid leukemia (CML-BC) vs. de novoAMLs with myelodysplastic characteristics (dn-AML-MDS).